clopenthixol has been researched along with scopolamine hydrobromide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelly, PH; Miller, RJ | 1 |
| Zetler, G | 1 |
| Khalifa, AE | 1 |
3 other study(ies) available for clopenthixol and scopolamine hydrobromide
| Article | Year |
|---|---|
The interaction of neuroleptic and muscarinic agents with central dopaminergic systems.
Topics: Adenylyl Cyclase Inhibitors; Animals; Apomorphine; Behavior, Animal; Chlorpromazine; Clopenthixol; Clozapine; Corpus Striatum; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Flupenthixol; Male; Methamphetamine; Models, Biological; Oxotremorine; Parasympathomimetics; Pimozide; Rats; Scopolamine; Substantia Nigra; Thioridazine; Tranquilizing Agents | 1975 |
Antistereotype effects of ceruletide and some neuroleptics differentiated by interactions with clonazepam, muscimol, scopolamine and clonidine.
Topics: Animals; Antipsychotic Agents; Ceruletide; Clonazepam; Clonidine; Clopenthixol; Fluphenazine; Haloperidol; Male; Methylphenidate; Mice; Muscimol; Scopolamine; Sincalide; Stereotyped Behavior | 1986 |
Pro-oxidant activity of zuclopenthixol in vivo: differential effect of the drug on brain oxidative status of scopolamine-treated rats.
Topics: Animals; Antipsychotic Agents; Brain; Cell Differentiation; Clopenthixol; Drug Combinations; Glutathione; Glutathione Peroxidase; Male; Malondialdehyde; Muscarinic Antagonists; Oxidation-Reduction; Oxidative Stress; Oxidoreductases; Rats; Rats, Wistar; Scopolamine; Superoxide Dismutase | 2004 |